Adjuvant immunotherapy with intrapleural Streptococcus pyogenes (OK-432) in lung cancer patients after resection.

Lee, Y C; Luh, S P; Wu, R M; Lee, C J

Lee, Y C; Luh, S P; Wu, R M; Lee, C J.

Affiliation

Lee YC; Department of Surgery, College of Medicine, National Taiwan University, R.O.C.

Cancer Immunol Immunother ; 39(4): 269-74, 1994 Oct.

Article in En | MEDLINE | ID: mdl-7954529

Subject(s)

Adjuvants, Immunologic/therapeutic use; Immunotherapy; Lung Neoplasms/therapy; Picibanil/therapeutic use; Aged; Combined Modality Therapy; Drug Administration Routes; Female; Humans; Leukocyte Count/drug effects; Leukocytes/drug effects; Leukocytes/immunology; Lung Neoplasms/immunology; Lung Neoplasms/surgery; Male; Middle Aged; Pleura; Prospective Studies

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Picibanil / Adjuvants, Immunologic / Immunotherapy / Lung Neoplasms Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Cancer Immunol Immunother Journal subject: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Year: 1994 Document type: Article Country of publication: Germany

Search on Google

Add to My VHL

XML

PubMed Links